tradingkey.logo
搜索

Helius Medical Technologies Inc

HSDT
添加自选
1.650USD
-0.050-2.94%
收盘 07-31 16:00美东报价延迟15分钟
90.69M总市值
0.00市盈率 TTM

Helius Medical Technologies Inc

1.650
-0.050-2.94%

关于 Helius Medical Technologies Inc 公司

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Helius Medical Technologies Inc简介

公司代码HSDT
公司名称Helius Medical Technologies Inc
上市日期Jun 27, 2014
CEOAndreeff (Dane C)
员工数量21
证券类型Ordinary Share
年结日Jun 27
公司地址642 Newtown Yardley Road
城市NEWTOWN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编18940
电话12159446100
网址https://heliusmedical.com/
公司代码HSDT
上市日期Jun 27, 2014
CEOAndreeff (Dane C)

Helius Medical Technologies Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
8.00K
+79.53%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
1.64K
-33.29%
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
8.00K
+79.53%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
1.64K
-33.29%
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--

常见问题

Helius Medical Technologies Inc的前五大股东是谁?

Helius Medical Technologies Inc 的前五大股东如下:Mr. Blane Walter

有多少机构持有Helius Medical Technologies Inc(HSDT)的股份?

截至2026Q1,共有61家机构持有Helius Medical Technologies Inc的股份,合计持有的股份价值约为16.40M,占公司总股份的28.25%。与2025Q4相比,机构持股有所增加,增幅为1284175.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有